Frontotemporal Disorders Treatment Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028


#14621

Future Market Insights

$ 5000

Dementia affects a large population of people across the world. The disorder, characteristic of old age, has been a matter of discussion across medical circles for several decades. The global frontotemporal disorders market is poised to expand at the back of advancements in the field of neurology. Research related to the human neurons has gained traction from world-renowned scientists. This factor has brought frontotemporal disorders treatment under the radar of focus. Ease in gathering data related to the incidence of frontotemporal dementia has given a thrust to market growth.

  • The National Institute of Neurological Disorders and Stroke in the US has helped in developing treatment lines for several neurological disorders. The institute supports research in over 600 areas related to neurological diseases. The inception of other similar institutes could foster unhindered growth in the global frontotemporal disorders treatment market.
  • Physical, mental, and emotional traumas are closely related to the occurrence of frontotemporal disorders. The count of traumatic brain injuries in the US stood at 2.87 million, according to a 2019 report. It can be inferred from the aforementioned statistic that the need for treating frontotemporal disorders is rising.
  • Based on geography, the North America frontotemporal disorders treatment market is expected to tread along a lucrative growth track. Supremacy of neurological research in the US is responsible for this regional growth. Other regional segments include Asia Pacific, Europe, and Rest of the World.

Athletes and military veterans have emerged as key consumers within the global frontotemporal disorders treatment market.  Furthermore, the use of new neural technologies has created tremendous scope for growth across this market.

Frontotemporal disorders, most commonly known as Pick’s disease, are damage to the nerve cells in specific area of brain that is frontal and temporal lobes. Frontotemporal disorders lead to dementia which alter the identity, conduct, dialect and development of muscles. Due to frontotemporal disorders, numerous conceivable indications may result, including strange practices, emotional issues, difficulty in working, or trouble with strolling. Frontotemporal degenerations are mainly caused due to group of brain disorders which involves protein tau and protein TDP43 which directly attack on the frontal and temporal lobes of the brain. Frontotemporal disorders is mainly subdivided into three types, Behavior Variant Frontotemporal Dementia (bvFTD), Primary progressive aphasia (PPA), and Disturbances of motor (movement or muscle) function. There is no curable treatment for frontotemporal disorders but certain medications can help in reducing the disturbance, peevishness as well as despondency.

According to Centers for Disease and Control, in 2010, around 35.6 million individuals were affected by dementia across the globe while it is expected to affect around 115.4 million individuals by 2050. Frontotemporal disorders gradually grows with respect to time leading to higher death rates.  Medications such as antidepressants and antipsychotics can help in curing symptoms of frontotemporal disorders.

Frontotemporal Disorders Treatment Market: Drivers and Restrains

Frontotemporal disorders are not only limited to patients but also indirectly affect people around them. Due to increase in aging population worldwide there is an increase in number of cases registered for frontotemporal disorder resulting in hike in the global frontotemporal disorder treatment market. As the illness is overpowering for overseers, therapeutic offices over the globe are taking a gander at arrangements, for example, home care administrations, mental treatment centers, and restorative devices for frontotemporal disorder patients has been the driving factor in the global frontotemporal disorder treatment market.

However, factors such as strict government regulations, poor treatment procedures, non-approval of drugs and lack of awareness amongst people is restraining the global frontotemporal disorder treatment market. Several challenges in developing innovative and novel therapies have also limited the growth of the market.

Frontotemporal Disorders Treatment Market: Segmentation

The global Frontotemporal Disorders Treatment Market has been classified on the basis of medication, disease type, and end user.

Based on medication, the global Frontotemporal Disorders Treatment Market is divided into following:

Antidepressants

  • Fluoxetine
  • Sertraline
  • Paroxetine
  • Fluvoxamine
  • Citalopram
  • Bupropion
  • Mitrazepine

Antipsychotics

  • Olanzepine
  • Quetiapine
  • Risperidone
  • Ziprasidone
  • Aripiprazole
  • Paliperidone

Based on disease type, the global Frontotemporal Disorders Treatment Market is divided into following:

  • Behavior Variant Frontotemporal Dementia (bvFTD)
  • Primary progressive aphasia (PPA)
  • Others

Based on end user, the global Frontotemporal Disorders Treatment Market is divided into following:

  • Hospitals
  • Specialty Clinics
  • Nursing Homes

Frontotemporal Disorders Treatment Market: Overview

The global frontotemporal disorders treatment market is segmented on the basis of medication, type of disease and end user. On the basis of medication, the global frontotemporal disorders treatment market is segmented into antidepressants and antipsychotics. Antidepressants are mainly prescribed as depression and anxiety are main symptoms of frontotemporal disorders treatment market. On the basis of type of disease, the global frontotemporal disorders treatment market is segmented into behavior variant frontotemporal dementia, primary progressive aphasia, and disturbances of motor function. PPA is further segmented into nonfluent variant of PPA and semantic variant of PPA. On the basis of end user, the global frontotemporal disorders treatment market is segmented into hospitals, specialty clinics, and nursing homes.

Frontotemporal Disorders Treatment Market: Regional Overview

The global Frontotemporal Disorders Treatment Market is segmented into North America, Latin America, Western Europe, Eastern Europe, and Asia Pacific excluding Japan and Middle East and Africa. North America leads the overall Frontotemporal Disorders Treatment Market.  Advancement in health care facilities, continuous lifestyle changes, gradual increase in awareness amongst people, surge in disposable income and favorable government policies have boosted the global spider veins treatment market in North America. Also in Asia region higher market growth rate is expected due to increase in prevalence and incidence rates due to aging population.

Frontotemporal Disorders Treatment Market: Key Players

Some of the key players competing in the global Frontotemporal Disorders Treatment Market are Novartis AG, Sanofi S.A., AstraZeneca GmbH, F. Hoffmann-La Roche, Merck & Co., Valeant Pharmaceutical International, and Pfizer, among others. Many new strategies including R&D investments, geographic expansion and competitive pricing policies adapted by players had helped to increase the global Frontotemporal Disorders Treatment Market.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

  • Tailwinds and headwinds molding the market’s trajectory
  • Market segments based on products, technology, and applications
  • Prospects of each segment
  • Overall current and possible future size of the market
  • Growth pace of the market
  • Competitive landscape and key players’ strategies

The main aim of the report is to:

  • Enable key stakeholder’s in the market bet right on it
  • Understand the opportunities and pitfalls awaiting them
  • Assess the overall growth scope in the near term
  • Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.